🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesMy dad had a heart attack and now I am terrified - will GLP-1 help? — need advice Page 2

My dad had a heart attack and now I am terrified - will GLP-1 help? — need advice

Dr.NephBHM_UK Sun, Oct 6, 2024 at 5:41 PM 15 replies 1,830 viewsPage 2 of 3
lucas_SP_BR
Member
456
1,890
Jun 2024
São Paulo, BR
Oct 7, 2024 at 1:43 AM#6
Dr.NephBHM_UK said:
SELECT is the trial that changed the framing of this class, because it was an outcome trial rather than a weight trial: about a 20% relative reduction…
Dr.NephBHM_UK said:
...we don't know the long-term effects of cardiovascular risk...

This is a fair point, and I think intellectual honesty requires acknowledging it. GLP-1 agonists in their current form have ~8-10 years of human exposure data. That's not nothing, but it's not 30+ years either.

However: the risk-benefit calculation should also consider the KNOWN long-term effects of untreated obesity — diabetes, cardiovascular disease, cancer, joint destruction, reduced lifespan by 5-10 years.

Uncertainty about GLP-1 long-term safety vs certainty about obesity consequences. The calculus seems clear to me, but reasonable people can disagree.

29 24NurseKim_ATL, paul_denver, TinaHashiRN and 26 others
Reply Quote Save Share Report
Dr.EndoIndy
Member
267
1,234
Oct 2024
Indianapolis, IN
Oct 7, 2024 at 4:53 AM#7

A narrower follow-up, since the general answer is now clear:

What did you change at the same time, and can you separate the two now?

28 23LeilaHI, marcus_mpls, DeniseRN_TPA and 25 others
Reply Quote Save Share Report
DebRD_ATL
Senior Member
1,678
7,890
Feb 2024
Atlanta, GA
Oct 7, 2024 at 8:03 AM#8
lucas_SP_BR said:
Dr.NephBHM_UK said: ...we don't know the long-term effects of cardiovascular risk...
lucas_SP_BR said:
...we're creating a generation dependent on cardiovascular risk...

I understand the concern, but consider this analogy: are we "creating a generation dependent on" blood pressure medication? Cholesterol medication? Thyroid medication?

Obesity is a chronic disease with biological drivers. Treating it with medication is no different from treating any other chronic condition. The "dependency" framing implies weakness or moral failure — neither of which is accurate.

If ongoing medication is what keeps someone healthy, that's successful treatment, not dependency.

27 22SleepDoc_PDX, RegAffairsDC, BiostatsBrad and 24 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.NephBHM_UK
Member
456
2,123
Jun 2024
Birmingham, UK
Oct 7, 2024 at 11:14 AM#9
lucas_SP_BR said:
Dr.NephBHM_UK said: ...we don't know the long-term effects of cardiovascular risk...

Senior perspective on cardiovascular risk: I'm 65 years old and started this journey skeptically. My geriatrician recommended it after years of failed interventions.

9 months later: down 38 lbs, more mobile, pain reduced, medications simplified. My quality of life has improved dramatically. I wish this existed 20 years ago.

To other older adults hesitating: the SELECT trial proved benefit in our age group. You deserve to feel good in your body regardless of age.

26 21SurmountFan_IN, PeptideChemSF, A1cHero_PHX and 23 others
Reply Quote Save Share Report
MikeFit_NJ
Senior Member
1,567
6,543
Apr 2024
New Jersey
Oct 8, 2024 at 2:29 AM#10
DebRD_ATL said:
lucas_SP_BR said: ...we're creating a generation dependent on cardiovascular risk...
DebRD_ATL said:
...cardiovascular risk is just another fad...

I understand the skepticism — we've all seen "miracle" weight loss solutions come and go. But consider what makes GLP-1 agonists different:

  • Phase 3 RCTs with thousands of participants (not 20-person pilot studies)
  • Published in NEJM, JAMA, Lancet (not press releases)
  • Replicated across multiple independent research groups
  • Proven cardiovascular and renal benefits beyond weight loss
  • Biological mechanism fully characterized at the receptor level

This isn't a fad — it's a new drug class supported by the highest level of clinical evidence. The comparison to past fads is understandable but inappropriate.

22 20Dr.EndoIndy, tom_AK, josh_phd_bmore and 19 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register